Skip to main content
Premium Trial:

Request an Annual Quote

Structural Bioinformatics Delivers Lead Compound To BioChem Pharma

Premium

SAN DIEGO--Privately held Structural Bioinformatics here announced that BioChem Pharma, a Canadian biopharmaceutical company, has accepted a lead compound for the treatment of a human viral infectious disease, triggering a milestone payment in the company's collaboration with BioChem Pharma.

Structural Bioinformatics began collaborating with BioChem in August 1997 to find leads for certain viral and cancer targets.

The new lead compound will now be further developed by BioChem. Structural Bioinformatics will receive future fees upon the fulfillment of additional milestones, including the successful completion of clinical trials.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.